logo

ABBV

Abbvie·NYSE
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --

ABBV fundamentals

Abbvie (ABBV) released its earnings on Oct 31, 2025: revenue was 15.78B (YoY +9.10%), beat estimates; EPS was 1.86 (YoY -38.00%), beat estimates.
Revenue / YoY
15.78B
+9.10%
EPS / YoY
1.86
-38.00%
Report date
Oct 31, 2025
ABBV Earnings Call Summary for Q3,2025
  • Record Growth: Q3 revenue $15.8B (+8.4% YoY), beating estimates by $300M.
  • Pipeline Power: Skyrizi/Rinvoq at $17.3B+ in 2025, neuroscience up 19.6% to $2.8B.
  • Dividend Boost: 5.5% increase to $1.73/share, supported by $13B+ free cash flow.
  • Strategic Expansion: $10B+ U.S. manufacturing investment; new API plant and biologics expansion.
  • Resilience: Outperformed in oncology (+$1.7B), neuroscience (+$2.8B), despite macro headwinds in aesthetics.
EPS
Revenue

Revenue & Expenses

ABBV has released its 2025 Q3 earnings report, with revenue of 15.78B, reflecting a YoY change of 9.10%, and net profit of 188.00M, showing a YoY change of -87.98%. The Sankey diagram below clearly presents ABBV's revenue sources and cost distribution.

Key Indicators

Abbvie (ABBV) key financial stats and ratios, covering profitability, financial health, and leverage.
Abbvie (ABBV)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Abbvie (ABBV)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Abbvie (ABBV)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Abbvie (ABBV) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Abbvie (ABBV) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield